Analysis of outcomes following autologous stem cell transplantation in adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia during first complete remission

• Harumi Kato,
• Takakazu Kawase,
• Shinichi Kako,
• Shuichi Mizuta,
• Mineo Kurokawa,
• Takehiko Mori,
• Kazuteru Ohashi,
• Koji Iwato,
• Koichi Miyamura,
• Michihiro Hidaka,
• Hisashi Sakamaki,
• Ritsuro Suzuki,
• Yasuo Morishima,
• Junji Tanaka

Affiliations

Harumi Kato

Department of Hematology and Cell Therapy, Aichi Cancer Center Hospital, Nagoya, Aichi, Japan

Takakazu Kawase

Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA, USA

Shinichi Kako

Division of Hematology, Saitama Medical Center, Jichi Medical University, Japan

Shuichi Mizuta

Department of Hematology, Fujita Health University Hospital, Toyoake, Aichi, Japan

Mineo Kurokawa

Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, Japan

Takehiko Mori

Division of Hematology, Keio University School of Medicine, Tokyo, Japan

Kazuteru Ohashi

Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Japan

Koji Iwato

Internal Medicine, Hiroshima Red Cross and Atomic-Bomb Survivals Hospital, Japan

Koichi Miyamura

Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Aichi, Japan

Michihiro Hidaka

Department of Hematology, National Hospital Organization Kumamoto Medical Center, Kumamoto, Japan

Hisashi Sakamaki

Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Japan

Ritsuro Suzuki

Department of HSCT Data Management and Biostatistics, Nagoya University School of Medicine, Nagoya, Aichi, Japan

Yasuo Morishima

Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan

Junji Tanaka

Department of Hematology, Tokyo Women’s Medical University, Tokyo, Japan